NBME Form 31 Practice Test

Decreased levels of dihydrotestosterone (DHT) and reduced activity of the enzyme 5-alpha reductase are particularly associated with the development and functioning of the prostate gland. DHT is a potent androgen derived from testosterone through the action of 5-alpha reductase, and it plays a key role in the growth and differentiation of prostate tissues.

In conditions where there is diminished production of DHT, such as in cases of 5-alpha reductase deficiency or certain forms of androgen insensitivity, the prostate may be underdeveloped or experience hypoplasia. This is particularly evident in clinical conditions like 5-alpha reductase deficiency, where individuals may have ambiguous genitalia at birth and reduced prostate size due to insufficient DHT for normal development.

While the kidneys, liver, and testes have their own pathways and mechanisms of hormone influence, they are not directly affected by DHT in the same way that the prostate is. Thus, the link between decreased DHT and the specific hypoplasia of the prostate is a clear and established connection in developmental biology and endocrinology.